Yaben Chemical (300261.SZ): Net loss of 455.7767 million yuan in the first quarter turned into a year-on-year loss

On April 28, Ge Longhui | Yaben Chemical (300261.SZ) released its first quarter report. Operating income was 220 million yuan, down 54.06% year on year. Net loss was 455.777 million yuan, which turned into loss year on year, after deducting non-net loss of 405.47 million yuan. The basic earnings per share were -0.0475 yuan.

Gelonghui FinanceApr 28 16:18

The CRO concept was active at the beginning of the market. Baihua Pharmaceutical rose more than 8%, Boji Pharmaceutical rose 7%, and Shuangcheng Pharmaceutical, Haofan Biotech, and Yaben Chemical followed suit.

The CRO concept was active at the beginning of the market. Baihua Pharmaceutical rose more than 8%, Boji Pharmaceutical rose 7%, and Shuangcheng Pharmaceutical, Haofan Biotech, and Yaben Chemical followed suit.

Zhitong FinanceApr 25 09:36

Express News | Yaben Chemical Lanzhou Antiviral Drug Pilot Project put into operation

BreakingsApr 19 08:23

Express News | YABON CHEMICAL: Subsidiary temporarily suspends production

BreakingsApr 10 19:28

Yaben Chemical (300261.SZ): As of March 20, 2024, the number of shareholders of the company was 6,7739

Gelonghui, April 10, 丨 Yaben Chemical (300261.SZ) said on the investor interactive platform that as of March 20, 2024, the number of shareholders of the company was 6,7739.

Gelonghui FinanceApr 10 17:44

Express News | Yaben Chemical had an in-depth exchange with Cody Wah

BreakingsApr 9 11:22